Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$17.60 -0.62 (-3.40%)
At close: Oct 2, 2026 · 4:00 PM EDT

Syndax Pharmaceuticals (SNDX) Cash & Current Investments (2015 - 2026)

Updated

Syndax Pharmaceuticals (SNDX) recorded Cash & Current Investments of $547.86 million in Q2 2026, up 20.3% from $455.23 million a year earlier and up 55.6% from the prior quarter.

Analysis

Syndax Pharmaceuticals (SNDX) Cash & Current Investments (2015 - 2026) Analysis & Trends

At the end of FY2025, Syndax Pharmaceuticals reported Cash & Current Investments of $394.07 million, down 31.2% from FY2024.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of 6.1% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $572.88 million in FY2024 (+0.4%), $570.7 million in FY2023 (+19.9%), $475.8 million in FY2022 (+8.1%) and $440.05 million in FY2021 (+50.1%).
  • The Q2 2026 figure is the highest quarterly Cash & Current Investments since Q4 2024.
  • On a year-over-year basis, Cash & Current Investments rose in six of the last eight quarters, with growth averaging 0.3%.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 50.1% in Q4 2021, against a decline of 31.3% in Q1 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $352.06 million (Q1 2026), $394.07 million (Q4 2025) and $435.98 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Syndax Pharmaceuticals 1.57 Bn -160.92 Mn 69.58 Mn 547.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 547.86 Mn
Mar 31, 2026 352.06 Mn
Dec 31, 2025 394.07 Mn
Sep 30, 2025 435.98 Mn
Jun 30, 2025 455.23 Mn
Mar 31, 2025 512.20 Mn
Dec 31, 2024 572.88 Mn
Sep 30, 2024 389.61 Mn
Jun 30, 2024 425.10 Mn
Mar 31, 2024 434.58 Mn
Dec 31, 2023 570.70 Mn
Sep 30, 2023 363.56 Mn
Jun 30, 2023 398.80 Mn
Mar 31, 2023 432.39 Mn
Dec 31, 2022 475.80 Mn
Sep 30, 2022 337.95 Mn
Jun 30, 2022 366.91 Mn
Mar 31, 2022 398.05 Mn
Dec 31, 2021 440.05 Mn
Sep 30, 2021 229.83 Mn
API Access

Syndax Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=SNDX&period=max&api_key=YOUR_API_KEY